Acambis Granted Fast Track Status for ACAM2000 Smallpox Vaccine
CAMBRIDGE, England and CAMBRIDGE, Mass. -- Acambis plc (Acambis) announced that its investigational smallpox vaccine ACAM2000 has been designated as a Fast Track product by the U.S. Food and Drug Administration (FDA).
Acambis has delivered 182.5 million doses of ACAM2000 to the U.S. government for its emergency-use Strategic National Stockpile and has orders from several other governments around the world for its investigational smallpox vaccine.
Acambis is currently proceeding toward the submission of a Biologics License Application (BLA) for ACAM2000 based upon data obtained in all ACAM2000 trials conducted, including clinical data from more than 2,900 subjects vaccinated in its phase 3 clinical trials.
Under the FDA Modernization Act of 1997, designation as a Fast Track product for a new drug or biological product means that FDA will take such actions as are appropriate to expedite the marketing application and approval for the product.
Acambis is working with Baxter Healthcare Corporation, part of Baxter International, Inc., to manufacture its investigational ACAM2000 for the United States and other governments, under the FDA's Investigational New Drug application for ACAM2000.
Source: Acambis plc
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
